Literature DB >> 2839969

The growing teratoma syndrome: an unusual manifestation of treated, nonseminomatous germ cell tumors of the testis.

J G Lorigan1, F Eftekhari, C L David, A Shirkhoda.   

Abstract

Residual masses are a common finding after chemotherapy for retroperitoneal and other metastases from nonseminomatous germ cell tumors of the testis. These may contain mature teratoma, fibrotic tissue, or tumor. Mature teratoma, which is unresponsive to chemotherapy, may result from evolution of a malignant lesion during treatment, or it may represent a metastasis from a focus of mature teratoma in the primary testicular tumor. An enlarging retroperitoneal mass during the course of chemotherapy is usually due to treatment failure but rarely may be due to an enlarging mature teratoma, the so-called growing teratoma syndrome. This report concerns five patients with nonseminomatous germ cell tumors metastatic to the retroperitoneum in whom mature teratomas were found at surgery. These tumors had grown despite the administration of combination systemic chemotherapy, and the cystic component had increased in size. Three patients had evidence of urinary tract compression, three had vascular compression or displacement, and one had gastrointestinal compression. The retroperitoneal mass was excised in each patient, and all are alive 4-27 months after surgery without evidence of recurrence. Growing mature teratoma is unresponsive to chemotherapy but is cured by surgical excision. The possibility of the growing teratoma syndrome should be considered so that these lesions can be treated appropriately.

Entities:  

Mesh:

Year:  1988        PMID: 2839969     DOI: 10.2214/ajr.151.2.325

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

Review 1.  Metastatic Mature Teratoma and Growing Teratoma Syndrome in Patients with Testicular Non-Seminomatous Germ Cell Tumors.

Authors:  Daniel B Green; Francisco G La Rosa; Paul G Craig; Francesca Khani; Elaine T Lam
Journal:  Korean J Radiol       Date:  2021-07-26       Impact factor: 7.109

2.  The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management.

Authors:  Anna C Pfannenberg; Karin Oechsle; Carsten Bokemeyer; Christian Kollmannsberger; Bernhard M Dohmen; Roland Bares; Jörg T Hartmann; Reinhard Vonthein; Claus D Claussen
Journal:  World J Urol       Date:  2004-01-21       Impact factor: 4.226

3.  Size and status of metastases after inductive chemotherapy of germ-cell tumors. Indication for salvage operation.

Authors:  N Jaeger; L Weissbach; R Bussar-Maatz
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

4.  Growing teratoma syndrome of ovary: avoiding a misdiagnosis of tumour recurrence.

Authors:  Ananya Panda; Devasenathipapathy Kandasamy; Chandrashekhara Sh; Manisha Jana
Journal:  J Clin Diagn Res       Date:  2014-01-12

5.  The growing teratoma syndrome secondary to immature teratoma of the ovary.

Authors:  Tsutomu Inaoka; Koji Takahashi; Tomonori Yamada; Naoyuki Miyokawa; Yoshihiko Tokusashi; Makoto Yoshida; Masaya Sugimoto; Kazutoshi Miyamoto; Tamio Aburano
Journal:  Eur Radiol       Date:  2002-10-15       Impact factor: 5.315

6.  Predicting necrosis in residual mass analysis after retroperitoneal lymph node dissection: a retrospective study.

Authors:  Eduardo de Paula Miranda; Daniel Kanda Abe; Adriano João Nesrallah; Sabrina Thalita dos Reis; Alexandre Crippa; Miguel Srougi; Marcos Francisco Dall'Oglio
Journal:  World J Surg Oncol       Date:  2012-09-28       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.